Gammagard Liquid Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials

Pharmacokinetics, Safety and Tolerability, and Efficacy Evaluation of Immune Globulin Subcutaneous (Human), 20% Solution (IGSC, 20%) in Japanese Participants With Primary Immunodeficiency Diseases (PID)
Condition:   Primary Immunodeficiency Diseases (PID) Interventions:   Biological: Immune Globulin Intravenous (IGIV);   Biological: Immune Globulin Subcutaneous, 20% Solution (IGSC, 20%) Sponsor:   Baxalta now part of Shire Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 15, 2020 Category: Research Source Type: clinical trials

Comparison of SYN023 to Human Rabies Immune Globulin in Post Exposure Prophylaxis of Rabies
Condition:   Rabies Interventions:   Biological: SYN023;   Biological: HRIG (HyperRab);   Biological: Rabies vaccine Sponsor:   Synermore Biologics Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 23, 2019 Category: Research Source Type: clinical trials